Glaukos Long Term Debt 2014-2024 | GKOS
Glaukos long term debt from 2014 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Glaukos long term debt for the quarter ending December 31, 2024 was $0.069B, a 80.34% decline year-over-year.
- Glaukos long term debt for 2024 was $0.069B, a 80.34% decline from 2023.
- Glaukos long term debt for 2023 was $0.353B, a 0.07% decline from 2022.
- Glaukos long term debt for 2022 was $0.354B, a 0.24% increase from 2021.
| Glaukos Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $69 |
| 2023 | $353 |
| 2022 | $354 |
| 2021 | $353 |
| 2020 | $250 |
| 2019 | $58 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $1 |
| 2014 | $9 |
| 2013 | $18 |
| Glaukos Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-12-31 | $69 |
| 2024-09-30 | $126 |
| 2024-06-30 | $127 |
| 2024-03-31 | $353 |
| 2023-12-31 | $353 |
| 2023-09-30 | $353 |
| 2023-06-30 | $353 |
| 2023-03-31 | $354 |
| 2022-12-31 | $354 |
| 2022-09-30 | $353 |
| 2022-06-30 | $353 |
| 2022-03-31 | $353 |
| 2021-12-31 | $353 |
| 2021-09-30 | $352 |
| 2021-06-30 | $73 |
| 2021-03-31 | $61 |
| 2020-12-31 | $250 |
| 2020-09-30 | $247 |
| 2020-06-30 | $244 |
| 2020-03-31 | $59 |
| 2019-12-31 | $58 |
| 2019-09-30 | $69 |
| 2019-06-30 | $68 |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | $1 |
| 2015-09-30 | $3 |
| 2015-06-30 | $12 |
| 2015-03-31 | $14 |
| 2014-12-31 | $9 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.235B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $200.815B | 87.96 |
| Thermo Fisher Scientific (TMO) | United States | $152.859B | 18.49 |
| Edwards Lifesciences (EW) | United States | $45.098B | 29.57 |
| Alcon (ALC) | Switzerland | $43.243B | 29.22 |
| IDEXX Laboratories (IDXX) | United States | $41.175B | 47.32 |
| DexCom (DXCM) | United States | $33.592B | 51.92 |
| IQVIA Holdings (IQV) | United States | $24.294B | 13.61 |
| STERIS (STE) | Ireland | $24.256B | 26.75 |
| Mettler-Toledo (MTD) | United States | $23.762B | 28.26 |
| Waters (WAT) | United States | $20.923B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.641B | 0.00 |
| Hologic (HOLX) | United States | $12.421B | 13.50 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $10.662B | 83.68 |
| Masimo (MASI) | United States | $8.371B | 30.88 |
| Globus Medical (GMED) | United States | $7.953B | 18.65 |
| Teleflex (TFX) | United States | $5.589B | 9.23 |
| Integer Holdings (ITGR) | United States | $4.155B | 21.77 |
| TransMedics (TMDX) | United States | $4.120B | 89.57 |
| PROCEPT BioRobotics (PRCT) | United States | $3.215B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.389B | 14.23 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.102B | 24.11 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.512B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 115.88 |
| Pulse Biosciences (PLSE) | United States | $1.109B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.011B | 5.38 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.75 |
| Mesa Laboratories (MLAB) | United States | $0.659B | 14.41 |
| Beta Bionics (BBNX) | United States | $0.597B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.590B | 9.17 |
| NeuroPace (NPCE) | United States | $0.560B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.559B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| RxSight (RXST) | United States | $0.541B | 0.00 |
| AxoGen (AXGN) | United States | $0.537B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.425B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.372B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.362B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.355B | 9.43 |
| Pacific Biosciences Of California (PACB) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.59 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| 908 Devices (MASS) | United States | $0.162B | 0.00 |
| CVRx (CVRX) | United States | $0.161B | 0.00 |
| Inogen (INGN) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
| InspireMD (NSPR) | Israel | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.062B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |